Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Attention Deficit Hyperactivity Disorder Symptoms and Psychosis in 22q11.2 Deletion Syndrome.

Niarchou M, Calkins ME, Moore TM, Tang SX, McDonald-McGinn DM, Zackai EH, Emanuel BS, Gur RC, Gur RE.

Schizophr Bull. 2018 Jun 6;44(4):824-833. doi: 10.1093/schbul/sbx113.

PMID:
29040797
2.

Subthreshold Psychosis in 22q11.2 Deletion Syndrome: Multisite Naturalistic Study.

Weisman O, Guri Y, Gur RE, McDonald-McGinn DM, Calkins ME, Tang SX, Emanuel B, Zackai EH, Eliez S, Schneider M, Schaer M, Kates WR, Antshel KM, Fremont W, Shashi V, Hooper SR, Armando M, Vicari S, Pontillo M, Kushan L, Jalbrzikowski M, Bearden CE, Cubells JF, Ousley OY, Walker EF, Simon TJ, Stoddard J, Niendam TA, van den Bree MBM, Gothelf D; International Consortium on Brain and Behavior in 22q11.2 Deletion Syndrome.

Schizophr Bull. 2017 Sep 1;43(5):1079-1089. doi: 10.1093/schbul/sbx005.

3.

The clinical presentation of attention deficit-hyperactivity disorder (ADHD) in children with 22q11.2 deletion syndrome.

Niarchou M, Martin J, Thapar A, Owen MJ, van den Bree MB.

Am J Med Genet B Neuropsychiatr Genet. 2015 Dec;168(8):730-8. doi: 10.1002/ajmg.b.32378. Epub 2015 Sep 24.

4.

Attention deficit hyperactivity disorder symptoms as antecedents of later psychotic outcomes in 22q11.2 deletion syndrome.

Niarchou M, Chawner SJRA, Fiksinski A, Vorstman JAS, Maeder J, Schneider M, Eliez S, Armando M, Pontillo M, Vicari S, McDonald-McGinn DM, Emanuel BS, Zackai EH, Bearden CE, Shashi V, Hooper SR, Owen MJ, Gur RE, Wray NR, van den Bree MBM, Thapar A; International 22q11.2 Deletion Syndrome Brain and Behavior Consortium.

Schizophr Res. 2018 Aug 7. pii: S0920-9964(18)30490-0. doi: 10.1016/j.schres.2018.07.044. [Epub ahead of print]

5.

Negative subthreshold psychotic symptoms distinguish 22q11.2 deletion syndrome from other neurodevelopmental disorders: A two-site study.

Mekori-Domachevsky E, Guri Y, Yi J, Weisman O, Calkins ME, Tang SX, Gross R, McDonald-McGinn DM, Emanuel BS, Zackai EH, Zalsman G, Weizman A, Gur RC, Gur RE, Gothelf D.

Schizophr Res. 2017 Oct;188:42-49. doi: 10.1016/j.schres.2016.12.023. Epub 2016 Dec 29.

6.

Cognitive behavioral therapy in 22q11.2 microdeletion with psychotic symptoms: What do we learn from schizophrenia?

Demily C, Franck N.

Eur J Med Genet. 2016 Nov;59(11):596-603. doi: 10.1016/j.ejmg.2016.09.007. Epub 2016 Sep 14.

PMID:
27639442
7.

The Psychosis Spectrum in 22q11.2 Deletion Syndrome Is Comparable to That of Nondeleted Youths.

Tang SX, Moore TM, Calkins ME, Yi JJ, Savitt A, Kohler CG, Souders MC, Zackai EH, McDonald-McGinn DM, Emanuel BS, Gur RC, Gur RE.

Biol Psychiatry. 2017 Jul 1;82(1):17-25. doi: 10.1016/j.biopsych.2016.08.034. Epub 2016 Sep 8.

8.

The dimensional structure of psychopathology in 22q11.2 Deletion Syndrome.

Niarchou M, Moore TM, Tang SX, Calkins ME, McDonald-McGuinn DM, Zackai EH, Emanuel BS, Gur RC, Gur RE.

J Psychiatr Res. 2017 Sep;92:124-131. doi: 10.1016/j.jpsychires.2017.04.006. Epub 2017 Apr 15.

PMID:
28433949
9.

Risk factors and the evolution of psychosis in 22q11.2 deletion syndrome: a longitudinal 2-site study.

Gothelf D, Schneider M, Green T, Debbané M, Frisch A, Glaser B, Zilkha H, Schaer M, Weizman A, Eliez S.

J Am Acad Child Adolesc Psychiatry. 2013 Nov;52(11):1192-1203.e3. doi: 10.1016/j.jaac.2013.08.008. Epub 2013 Aug 29.

PMID:
24157393
10.

Psychiatric disorders in 22q11.2 deletion syndrome are prevalent but undertreated.

Tang SX, Yi JJ, Calkins ME, Whinna DA, Kohler CG, Souders MC, McDonald-McGinn DM, Zackai EH, Emanuel BS, Gur RC, Gur RE.

Psychol Med. 2014 Apr;44(6):1267-77. doi: 10.1017/S0033291713001669. Epub 2013 Sep 9.

11.

The feasibility and safety of S-adenosyl-L-methionine (SAMe) for the treatment of neuropsychiatric symptoms in 22q11.2 deletion syndrome: a double-blind placebo-controlled trial.

Green T, Steingart L, Frisch A, Zarchi O, Weizman A, Gothelf D.

J Neural Transm (Vienna). 2012 Nov;119(11):1417-23. doi: 10.1007/s00702-012-0831-x. Epub 2012 Jun 8.

PMID:
22678699
12.

[Neurocognitive and psychiatric management of the 22q11.2 deletion syndrome].

Demily C, Rossi M, Schneider M, Edery P, Leleu A, d'Amato T, Franck N, Eliez S.

Encephale. 2015 Jun;41(3):266-73. doi: 10.1016/j.encep.2014.10.005. Epub 2014 Dec 16. Review. French.

PMID:
25523123
13.

Further evidence for high rates of schizophrenia in 22q11.2 deletion syndrome.

Monks S, Niarchou M, Davies AR, Walters JT, Williams N, Owen MJ, van den Bree MB, Murphy KC.

Schizophr Res. 2014 Mar;153(1-3):231-6. doi: 10.1016/j.schres.2014.01.020. Epub 2014 Feb 15.

PMID:
24534796
14.

Predominant negative symptoms in 22q11.2 deletion syndrome and their associations with cognitive functioning and functional outcome.

Schneider M, Van der Linden M, Menghetti S, Glaser B, Debbané M, Eliez S.

J Psychiatr Res. 2014 Jan;48(1):86-93. doi: 10.1016/j.jpsychires.2013.10.010. Epub 2013 Oct 25.

PMID:
24189154
15.

Association of COMT and PRODH gene variants with intelligence quotient (IQ) and executive functions in 22q11.2DS subjects.

Carmel M, Zarchi O, Michaelovsky E, Frisch A, Patya M, Green T, Gothelf D, Weizman A.

J Psychiatr Res. 2014 Sep;56:28-35. doi: 10.1016/j.jpsychires.2014.04.019. Epub 2014 May 9.

PMID:
24853458
16.

Developmental trajectories in 22q11.2 deletion.

Swillen A, McDonald-McGinn D.

Am J Med Genet C Semin Med Genet. 2015 Jun;169(2):172-81. doi: 10.1002/ajmg.c.31435. Epub 2015 May 18. Review.

17.

Psychiatric disorders from childhood to adulthood in 22q11.2 deletion syndrome: results from the International Consortium on Brain and Behavior in 22q11.2 Deletion Syndrome.

Schneider M, Debbané M, Bassett AS, Chow EW, Fung WL, van den Bree M, Owen M, Murphy KC, Niarchou M, Kates WR, Antshel KM, Fremont W, McDonald-McGinn DM, Gur RE, Zackai EH, Vorstman J, Duijff SN, Klaassen PW, Swillen A, Gothelf D, Green T, Weizman A, Van Amelsvoort T, Evers L, Boot E, Shashi V, Hooper SR, Bearden CE, Jalbrzikowski M, Armando M, Vicari S, Murphy DG, Ousley O, Campbell LE, Simon TJ, Eliez S; International Consortium on Brain and Behavior in 22q11.2 Deletion Syndrome.

Am J Psychiatry. 2014 Jun;171(6):627-39. Review.

18.

The social brain network in 22q11.2 deletion syndrome: a diffusion tensor imaging study.

Olszewski AK, Kikinis Z, Gonzalez CS, Coman IL, Makris N, Gong X, Rathi Y, Zhu A, Antshel KM, Fremont W, Kubicki MR, Bouix S, Shenton ME, Kates WR.

Behav Brain Funct. 2017 Feb 16;13(1):4. doi: 10.1186/s12993-017-0122-7.

19.

Biological effects of COMT haplotypes and psychosis risk in 22q11.2 deletion syndrome.

Gothelf D, Law AJ, Frisch A, Chen J, Zarchi O, Michaelovsky E, Ren-Patterson R, Lipska BK, Carmel M, Kolachana B, Weizman A, Weinberger DR.

Biol Psychiatry. 2014 Mar 1;75(5):406-13. doi: 10.1016/j.biopsych.2013.07.021. Epub 2013 Aug 28.

20.

Association between a common haplotype in the COMT gene region and psychiatric disorders in individuals with 22q11.2DS.

Michaelovsky E, Gothelf D, Korostishevsky M, Frisch A, Burg M, Carmel M, Steinberg T, Inbar D, Apter A, Weizman A.

Int J Neuropsychopharmacol. 2008 May;11(3):351-63. Epub 2007 Oct 22.

PMID:
17949513

Supplemental Content

Support Center